Skip to main content
Top
Published in: Journal of Cardiothoracic Surgery 1/2023

Open Access 01-12-2023 | Research

The survival benefit from surgery on patients with large-cell neuroendocrine carcinoma in the lung: a propensity-score matching study

Authors: Hao Jiang, Weixia Xie, Xianpeng Li, Huaying Wang, Wan-Jun Yu, Xiaolu Chen

Published in: Journal of Cardiothoracic Surgery | Issue 1/2023

Login to get access

Abstract

Purpose

This study aimed to investigate the prognostic significance of surgery in large-cell neuroendocrine carcinoma (LCNC) patients.

Methods

A total of 453 patients from the Surveillance, Epidemiology, and End Results database diagnosed with stage T1-4N0-2M0 LCNC from 2010 to 2015 were analyzed. The propensity-score matching analysis with a ratio of 1:1 was used to minimize the bias effect of other clinical characteristics, and 77 pairs of patients’ data were performed for subsequent statistical analysis. The Cox proportional hazards model, Kaplan-Meier analysis, and Log-rank test were used in the present study. The primary observational endpoint was cancer-specific survival (CSS).

Results

The 1-year, 3-year, and 5-year CSS rates were 60.0%, 45.0%, and 42.0% in those 453 LCNC patients. Compared with patients who underwent surgical resection, patients without surgery had a lower 5-year CSS rate (18.0% vs. 52.0%, P < 0.001). After analyses of multivariable Cox regression, chemotherapy, T stage, N stage, and surgery were identified as independent prognostic indicators (all P < 0.05). In the cohort of old patients, the median survival time was longer in cases after surgery than those without surgery (13.0 months vs. NA, P < 0.001). Besides, in patients with different clinical characteristics, the receiving surgery was a protective prognostic factor (all hazard ratio < 1, all P < 0.05). In addition, for the cohort with stage T1-2N0-2M0, patients after the operation had more improved outcomes than patients without surgery (P < 0.001).

Conclusions

We proposed that the surgery could improve the survival outcomes of LCNC patients with stage T1-4N0-2M0. Moreover, old patients could benefit from surgery.
Literature
1.
go back to reference Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.CrossRefPubMed Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.CrossRefPubMed
2.
go back to reference Wu LL, Li CW, Lin WK, Qiu LH, Xie D. Incidence and survival analyses for occult lung cancer between 2004 and 2015: a population-based study. BMC Cancer. 2021;21(1):1009.CrossRefPubMedPubMedCentral Wu LL, Li CW, Lin WK, Qiu LH, Xie D. Incidence and survival analyses for occult lung cancer between 2004 and 2015: a population-based study. BMC Cancer. 2021;21(1):1009.CrossRefPubMedPubMedCentral
3.
go back to reference Zheng R, Zhang S, Wang S, Chen R, Sun K, Zeng H, Li L, Wei W, He J. Lung cancer incidence and mortality in China: updated statistics and an overview of temporal trends from 2000 to 2016. J Natl Cancer Cent. 2022;2(3):139–47.CrossRef Zheng R, Zhang S, Wang S, Chen R, Sun K, Zeng H, Li L, Wei W, He J. Lung cancer incidence and mortality in China: updated statistics and an overview of temporal trends from 2000 to 2016. J Natl Cancer Cent. 2022;2(3):139–47.CrossRef
4.
go back to reference Haruki T, Matsui S, Oshima Y, Maeta H, Fukino S, Yurugi Y, Araki K, Umekita Y, Nakamura H. Prognostic impact of surgical treatment for high-grade neuroendocrine carcinoma of the lung: a multi-institutional retrospective study. J Thorac Dis. 2022;14(4):1070–8.CrossRefPubMedPubMedCentral Haruki T, Matsui S, Oshima Y, Maeta H, Fukino S, Yurugi Y, Araki K, Umekita Y, Nakamura H. Prognostic impact of surgical treatment for high-grade neuroendocrine carcinoma of the lung: a multi-institutional retrospective study. J Thorac Dis. 2022;14(4):1070–8.CrossRefPubMedPubMedCentral
5.
go back to reference Wakeam E, Acuna SA, Leighl NB, Giuliani ME, Finlayson SRG, Varghese TK, Darling GE. Surgery Versus Chemotherapy and Radiotherapy for Early and locally Advanced Small Cell Lung Cancer: a propensity-matched analysis of Survival. Lung Cancer. 2017;109:78–88.CrossRefPubMed Wakeam E, Acuna SA, Leighl NB, Giuliani ME, Finlayson SRG, Varghese TK, Darling GE. Surgery Versus Chemotherapy and Radiotherapy for Early and locally Advanced Small Cell Lung Cancer: a propensity-matched analysis of Survival. Lung Cancer. 2017;109:78–88.CrossRefPubMed
6.
go back to reference Chen X, Zhu JL, Wang H, Yu W, Xu T. Surgery and surgery Approach affect survival of patients with Stage I-IIA Small-Cell Lung Cancer: a study based SEER database by Propensity score matching analysis. Front Surg. 2022;9:735102.CrossRefPubMedPubMedCentral Chen X, Zhu JL, Wang H, Yu W, Xu T. Surgery and surgery Approach affect survival of patients with Stage I-IIA Small-Cell Lung Cancer: a study based SEER database by Propensity score matching analysis. Front Surg. 2022;9:735102.CrossRefPubMedPubMedCentral
7.
go back to reference Jiang WM, Wu LL, Wei HY, Ma QL, Zhang Q. A parsimonious Prognostic Model and Heat Map for Predicting Survival following adjuvant Radiotherapy in Parotid Gland Carcinoma with Lymph Node Metastasis. Technol Cancer Res Treat. 2021;20:15330338211035257.CrossRefPubMedPubMedCentral Jiang WM, Wu LL, Wei HY, Ma QL, Zhang Q. A parsimonious Prognostic Model and Heat Map for Predicting Survival following adjuvant Radiotherapy in Parotid Gland Carcinoma with Lymph Node Metastasis. Technol Cancer Res Treat. 2021;20:15330338211035257.CrossRefPubMedPubMedCentral
8.
go back to reference Liu X, Wu L, Zhang D, Lin P, Long H, Zhang L, Ma G. Prognostic impact of lymph node metastasis along the left gastric artery in esophageal squamous cell carcinoma. J Cardiothorac Surg. 2021;16(1):124.CrossRefPubMedPubMedCentral Liu X, Wu L, Zhang D, Lin P, Long H, Zhang L, Ma G. Prognostic impact of lymph node metastasis along the left gastric artery in esophageal squamous cell carcinoma. J Cardiothorac Surg. 2021;16(1):124.CrossRefPubMedPubMedCentral
9.
go back to reference Wu L-L, Li C-W, Li K, Qiu L-H, Xu S-Q, Lin W-K, Ma G-W, Li Z-X, Xie D. The difference and significance of Parietal Pleura Invasion and Rib Invasion in pathological T classification with Non-Small Cell Lung Cancer. Front Oncol 2022, 12. Wu L-L, Li C-W, Li K, Qiu L-H, Xu S-Q, Lin W-K, Ma G-W, Li Z-X, Xie D. The difference and significance of Parietal Pleura Invasion and Rib Invasion in pathological T classification with Non-Small Cell Lung Cancer. Front Oncol 2022, 12.
10.
go back to reference Lee SH, Seo HY, Kim HR, Song EK, Seon JK. Older age increases the risk of revision and perioperative complications after high tibial osteotomy for unicompartmental knee osteoarthritis. Sci Rep. 2021;11(1):24340.CrossRefPubMedPubMedCentral Lee SH, Seo HY, Kim HR, Song EK, Seon JK. Older age increases the risk of revision and perioperative complications after high tibial osteotomy for unicompartmental knee osteoarthritis. Sci Rep. 2021;11(1):24340.CrossRefPubMedPubMedCentral
11.
go back to reference Liu P, Wang Z, Zhang S, Ding G, Tan K, Zhou J. Application of endoprosthetic replacement in old patients with isolated proximal femoral bone metastases. Ann Surg Oncol 2022. Liu P, Wang Z, Zhang S, Ding G, Tan K, Zhou J. Application of endoprosthetic replacement in old patients with isolated proximal femoral bone metastases. Ann Surg Oncol 2022.
12.
go back to reference Taioli E, Flores R. Appropriateness of Surgical Approach in Black Patients with Lung Cancer-15 years later, little has changed. J Thorac Oncol. 2017;12(3):573–7.CrossRefPubMed Taioli E, Flores R. Appropriateness of Surgical Approach in Black Patients with Lung Cancer-15 years later, little has changed. J Thorac Oncol. 2017;12(3):573–7.CrossRefPubMed
13.
go back to reference Huang W, Wu L, Liu X, Long H, Rong T, Ma G. Preoperative serum C-reactive protein levels and postoperative survival in patients with esophageal squamous cell carcinoma: a propensity score matching analysis. J Cardiothorac Surg. 2019;14(1):167.CrossRefPubMedPubMedCentral Huang W, Wu L, Liu X, Long H, Rong T, Ma G. Preoperative serum C-reactive protein levels and postoperative survival in patients with esophageal squamous cell carcinoma: a propensity score matching analysis. J Cardiothorac Surg. 2019;14(1):167.CrossRefPubMedPubMedCentral
14.
go back to reference Petrella F, Bardoni C, Casiraghi M, Spaggiari L. The role of surgery in High-Grade Neuroendocrine Cancer: indications for clinical practice. Front Med. 2022;9:869320.CrossRef Petrella F, Bardoni C, Casiraghi M, Spaggiari L. The role of surgery in High-Grade Neuroendocrine Cancer: indications for clinical practice. Front Med. 2022;9:869320.CrossRef
15.
go back to reference Girelli L, Casiraghi M, Sandri A, Petrella F, Galetta D, Gasparri R, Maisonneuve P, Fazio N, Spaggiari L. Results of Surgical Resection of locally Advanced Pulmonary neuroendocrine tumors. Ann Thorac Surg. 2021;112(2):405–14.CrossRefPubMed Girelli L, Casiraghi M, Sandri A, Petrella F, Galetta D, Gasparri R, Maisonneuve P, Fazio N, Spaggiari L. Results of Surgical Resection of locally Advanced Pulmonary neuroendocrine tumors. Ann Thorac Surg. 2021;112(2):405–14.CrossRefPubMed
16.
go back to reference Casiraghi M, Sedda G, Del Signore E, Piperno G, Maisonneuve P, Petrella F, de Marinis F, Spaggiari L. Surgery for small cell lung cancer: when and how. Lung Cancer. 2021;152:71–7.CrossRefPubMed Casiraghi M, Sedda G, Del Signore E, Piperno G, Maisonneuve P, Petrella F, de Marinis F, Spaggiari L. Surgery for small cell lung cancer: when and how. Lung Cancer. 2021;152:71–7.CrossRefPubMed
17.
go back to reference Gao L, Shen L, Wang K, Lu S. Propensity score matched analysis for the role of surgery in stage small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a chinese hospital. Lung Cancer. 2021;162:54–60.CrossRefPubMed Gao L, Shen L, Wang K, Lu S. Propensity score matched analysis for the role of surgery in stage small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a chinese hospital. Lung Cancer. 2021;162:54–60.CrossRefPubMed
18.
go back to reference Liu B, Qian JY, Wu LL, Zeng JQ, Xu SQ, Yuan JH, Zheng YL, Xie D, Chen X, Yu HH. A long waiting time from diagnosis to treatment decreases the survival of non-small cell lung cancer patients with stage IA1: a retrospective study. Front Surg. 2022;9:987075.CrossRefPubMedPubMedCentral Liu B, Qian JY, Wu LL, Zeng JQ, Xu SQ, Yuan JH, Zheng YL, Xie D, Chen X, Yu HH. A long waiting time from diagnosis to treatment decreases the survival of non-small cell lung cancer patients with stage IA1: a retrospective study. Front Surg. 2022;9:987075.CrossRefPubMedPubMedCentral
19.
go back to reference Wu LL, Qian JY, Li CW, Zhang Y, Lin WK, Li K, Li ZX, Xie D. The Clinical and Prognostic Characteristics of Primary Salivary Gland-Type Carcinoma in the Lung: A Population-Based Study. Cancers (Basel) 2022, 14(19). Wu LL, Qian JY, Li CW, Zhang Y, Lin WK, Li K, Li ZX, Xie D. The Clinical and Prognostic Characteristics of Primary Salivary Gland-Type Carcinoma in the Lung: A Population-Based Study. Cancers (Basel) 2022, 14(19).
20.
go back to reference Rogers SO Jr, Gray SW, Landrum MB, Klabunde CN, Kahn KL, Fletcher RH, Clauser S, Tisnado D, Doucette W, Keating NL. Variations in surgeon treatment recommendations for lobectomy in early-stage non-small-cell lung cancer by patient age and comorbidity. Ann Surg Oncol. 2010;17(6):1581–8.CrossRefPubMedPubMedCentral Rogers SO Jr, Gray SW, Landrum MB, Klabunde CN, Kahn KL, Fletcher RH, Clauser S, Tisnado D, Doucette W, Keating NL. Variations in surgeon treatment recommendations for lobectomy in early-stage non-small-cell lung cancer by patient age and comorbidity. Ann Surg Oncol. 2010;17(6):1581–8.CrossRefPubMedPubMedCentral
21.
go back to reference Ye X, Liu Y, Yang J, Wang Y, Cui X, Xie H, Song L, Ding Z, Zhai R, Han Y, et al. Do older patients with stage IB non-small-cell lung cancer obtain survival benefits from surgery? A propensity score matching study using SEER data. Eur J Surg Oncol. 2022;48(9):1954–63.CrossRefPubMed Ye X, Liu Y, Yang J, Wang Y, Cui X, Xie H, Song L, Ding Z, Zhai R, Han Y, et al. Do older patients with stage IB non-small-cell lung cancer obtain survival benefits from surgery? A propensity score matching study using SEER data. Eur J Surg Oncol. 2022;48(9):1954–63.CrossRefPubMed
22.
go back to reference Sandler BJ, Wang Z, Hancock JG, Boffa DJ, Detterbeck FC, Kim AW. Gender, Age, and Comorbidity Status Predict Improved Survival with Adjuvant Chemotherapy following lobectomy for non-small cell lung cancers larger than 4 cm. Ann Surg Oncol. 2016;23(2):638–45.CrossRefPubMed Sandler BJ, Wang Z, Hancock JG, Boffa DJ, Detterbeck FC, Kim AW. Gender, Age, and Comorbidity Status Predict Improved Survival with Adjuvant Chemotherapy following lobectomy for non-small cell lung cancers larger than 4 cm. Ann Surg Oncol. 2016;23(2):638–45.CrossRefPubMed
23.
go back to reference Soldath P, Binderup T, Carstensen F, Clausen MM, Kjaer A, Federspiel B, Knigge U, Langer SW, Petersen RH. Long-term outcomes after video-assisted thoracoscopic surgery in pulmonary large-cell neuroendocrine carcinoma. Surg Oncol. 2022;41:101728.CrossRefPubMed Soldath P, Binderup T, Carstensen F, Clausen MM, Kjaer A, Federspiel B, Knigge U, Langer SW, Petersen RH. Long-term outcomes after video-assisted thoracoscopic surgery in pulmonary large-cell neuroendocrine carcinoma. Surg Oncol. 2022;41:101728.CrossRefPubMed
Metadata
Title
The survival benefit from surgery on patients with large-cell neuroendocrine carcinoma in the lung: a propensity-score matching study
Authors
Hao Jiang
Weixia Xie
Xianpeng Li
Huaying Wang
Wan-Jun Yu
Xiaolu Chen
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Journal of Cardiothoracic Surgery / Issue 1/2023
Electronic ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-023-02314-1

Other articles of this Issue 1/2023

Journal of Cardiothoracic Surgery 1/2023 Go to the issue